EMA 发布检查员工作组 2026—2028 年工作计划,列明 GMP 章节与附录修订时间表
New EMA GMP Guidelines in the next three Years
EMA 发布了新版检查员工作组三年工作计划,覆盖 2026 年 1 月至 2028 年 12 月,由 GMDP 检查员工作组制定。计划拟在 2026 年底前定稿 Chapter 1(药品质量体系)、Chapter 4(文件)、Annex 15(确认与验证)和 Annex 22(人工智能),并向欧盟委员会提交最终文本,同时至少对先进治疗药品 GMP 指南进行审查。
The European Medicines Agency (EMA) has published a new version of the '3-year work plan for the Inspectors Working Group' covering the period from January 2026 to December 2028. The plan is drawn up by the GMDP Inspectors Working Group (GMDP IWG). It also includes, in some cases, revised timelines for the revision of GMP requirements. The following chapters and annexes are to be finalised by the end of 2026 ("provide the European Commission with a final text"): Chapter 1 (Pharmaceutical Quality System) Chapter 4 (Documentation) Annex 15 Qualification and Validation Annex 22 Artificial IntelligenceAt least a review is to be carried out for the "Guidelines on Good Manufacturing Practice specific to Advanced Therapy Medicinal Products". The procedure for implementing the ICH Q12 guideline "Lifecycle Management" is also to be clarified by the end of the year. A great deal of work is then planned for the next two years, and the revisions to the following chapters and annexes are to be finalised by the end of 2028: Chapter 3 (Premises and Equipment) Chapter 5 (Production) Chapter 7 (Outsourced Activities) Chapter 9 (Self-Inspection) Annex 3 Manufacture of Radiopharmaceuticals Annex 6 Manufacture of Medicinal Gases Annex 14 Manufacture of Medicinal Products Derived from Human Blood or PlasmaFurther details can be found in the current document The 3-year work plan for the Inspectors Working Group.
来源:ECA GMP News · gmp-compliance.org